Assay platform released to Z'-LYTE of all

FRAMINGHAM (10/23/2003) - The Z'-LYTE assay platform from Invitrogen Corp. is a fluorescence-based biochemical detection technology used to screen for potential inhibitors of protein kinases and phosphatases. Designed for high-throughput screening applications, Z'-LYTE employs the Fluorescence Resonance Energy Transfer (FRET) assay method for quick assay development and consistent results.

Compatible with most automated systems, Z'-LYTE does not require radioactive or antibody-based reagents. Invitrogen offers custom assay development services for increased flexibility.

BLAzing New Trails Invitrogen is also promoting GeneBLAzer Technology research tools, a reporter technology based on the enzyme ß-lactamase. The company acquired the rights to GeneBLAzer from Pan Vera in March.

Vendor: Invitrogen

Product Name: Z'-LYTE

Availability: Now

For more information: www.invitrogen.com

Join the newsletter!

Error: Please check your email address.

More about InvitrogenTechnology Research

Show Comments
[]